SK281127B6 - Použitie inhibítora serínovej leukocytovej proteázy - Google Patents

Použitie inhibítora serínovej leukocytovej proteázy Download PDF

Info

Publication number
SK281127B6
SK281127B6 SK297-95A SK29795A SK281127B6 SK 281127 B6 SK281127 B6 SK 281127B6 SK 29795 A SK29795 A SK 29795A SK 281127 B6 SK281127 B6 SK 281127B6
Authority
SK
Slovakia
Prior art keywords
slpi
cells
hiv
mutein
infection
Prior art date
Application number
SK297-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK29795A3 (en
Inventor
Stephen Eisenberg
Sharon M. Wahl
Robert C. Thompson
Original Assignee
Amgen Inc.
Dept. Of Health A. Human Services Office Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc., Dept. Of Health A. Human Services Office Of Technology filed Critical Amgen Inc.
Publication of SK29795A3 publication Critical patent/SK29795A3/sk
Publication of SK281127B6 publication Critical patent/SK281127B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SK297-95A 1992-09-09 1993-09-09 Použitie inhibítora serínovej leukocytovej proteázy SK281127B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (fr) 1992-09-09 1993-09-09 Inhibition d'infection retrovirale

Publications (2)

Publication Number Publication Date
SK29795A3 SK29795A3 (en) 1997-02-05
SK281127B6 true SK281127B6 (sk) 2000-12-11

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
SK297-95A SK281127B6 (sk) 1992-09-09 1993-09-09 Použitie inhibítora serínovej leukocytovej proteázy

Country Status (23)

Country Link
EP (1) EP0666755B1 (fr)
JP (2) JP3517238B2 (fr)
KR (1) KR100273620B1 (fr)
AT (1) ATE238062T1 (fr)
AU (1) AU681350B2 (fr)
CA (1) CA2141951C (fr)
CZ (1) CZ286953B6 (fr)
DE (1) DE69332904T2 (fr)
DK (1) DK0666755T3 (fr)
ES (1) ES2197153T3 (fr)
FI (1) FI951078A0 (fr)
HU (1) HU218892B (fr)
NO (1) NO315546B1 (fr)
NZ (1) NZ256246A (fr)
OA (1) OA10133A (fr)
PL (1) PL307864A1 (fr)
PT (1) PT666755E (fr)
RO (1) RO116164B1 (fr)
RU (1) RU2126266C1 (fr)
SG (1) SG48115A1 (fr)
SK (1) SK281127B6 (fr)
UA (1) UA41338C2 (fr)
WO (1) WO1994006454A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1144488A (zh) * 1994-03-23 1997-03-05 东京田边制药株式会社 新型呼吸道病毒性疾病治疗药物
AU6530696A (en) * 1995-07-24 1997-02-18 Tokyo Tanabe Company Limited Remedy for viral diseases
DK0861085T3 (da) 1995-11-13 2005-11-21 Vitaleech Bioscience N V Antivirale isolater opnået fra igler
AU780121B2 (en) * 1999-05-13 2005-03-03 Japan Science And Technology Agency Inhibitors for viral infection targeting integrase N-terminal region
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
WO2005046732A2 (fr) 2003-11-04 2005-05-26 THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH Methodes et compositions d'inhibition de la replication du vih-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340877C (fr) * 1987-12-28 2000-01-18 Takashi Sugiyama Polypeptide inhibant l'elastage et procede de production par la technologie de l'adn recombinant
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (fr) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Usage pharmaceutique du trypstatin
DE69029970T2 (de) * 1989-08-16 1997-06-19 Chiron Corp Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
DK0506769T3 (da) * 1989-12-18 1994-11-28 Transgene Sa Farmaceutisk præparat til behandling eller forebyggelse af retrovirus-infektioner
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
AU681350B2 (en) 1997-08-28
HU9500682D0 (en) 1995-04-28
AU4853093A (en) 1994-04-12
ES2197153T3 (es) 2004-01-01
HU218892B (hu) 2000-12-28
DE69332904D1 (de) 2003-05-28
CA2141951A1 (fr) 1994-03-31
PL307864A1 (en) 1995-06-26
CZ286953B6 (en) 2000-08-16
CZ55995A3 (en) 1996-01-17
FI951078A (fi) 1995-03-08
WO1994006454A2 (fr) 1994-03-31
NO315546B1 (no) 2003-09-22
JP3517238B2 (ja) 2004-04-12
RU95109909A (ru) 1997-03-27
EP0666755B1 (fr) 2003-04-23
DE69332904T2 (de) 2003-11-06
UA41338C2 (uk) 2001-09-17
NO950897D0 (no) 1995-03-08
JPH08505042A (ja) 1996-06-04
CA2141951C (fr) 2007-04-24
SK29795A3 (en) 1997-02-05
HUT75126A (en) 1997-04-28
NO950897L (no) 1995-03-08
SG48115A1 (en) 1998-04-17
PT666755E (pt) 2003-09-30
RO116164B1 (ro) 2000-11-30
FI951078A0 (fi) 1995-03-08
OA10133A (en) 1996-12-18
KR950703357A (ko) 1995-09-20
RU2126266C1 (ru) 1999-02-20
EP0666755A1 (fr) 1995-08-16
WO1994006454A3 (fr) 1994-08-18
KR100273620B1 (ko) 2000-12-15
DK0666755T3 (da) 2003-08-04
NZ256246A (en) 1997-08-22
JP2004002455A (ja) 2004-01-08
ATE238062T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ES2257752T3 (es) Uso de roxitromicina para la preparacion de un medicamento para mejorar la actividad biologica y antiviral de inhibidores de proteasa.
EP0675730B1 (fr) Association therapeutique contenant l'interferon
AU723537B2 (en) The treatment of HIV and other viral infections using combinatorial therapy
EP2377880A2 (fr) Thérapie de combinaison d'inhibitors de fusion/entrée du VIH ciblant gp41
US5627035A (en) Peptides that block human immunodeficiency virus and methods of use thereof
US6017880A (en) Inhibition of retrovirus infection
SK281127B6 (sk) Použitie inhibítora serínovej leukocytovej proteázy
Richman Antiviral therapy of HIV infection
RU2290197C2 (ru) Фармацевтическое средство для лечения вич-инфекции, содержащая его композиция и способы его применения
JPH07267874A (ja) Ｈｉｖ感染に対する組合せ化学療法
US6869925B1 (en) Inhibition of retrovirus infection
JP2804979B2 (ja) エイズ治療および阻害剤
EP1075270B1 (fr) Peptide court destine au traitement des maladies neurodegeneratives
JP3770624B2 (ja) ウィルス感染・増殖抑制剤
KR100220531B1 (ko) 인간의 면역 결핍 바이러스 감염을 차단시키는 펩티드 및 그것의 사용 방법
Pomerantz et al. Therapy of human immunodeficiency virus infections
AU3831889A (en) Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection
HU201679B (en) Process for producing synergetic pharmaceutical compositions against retrovirus contaminations
MXPA97009682A (en) The treatment of hiv infections and other viral infections using a combined therapy